Artificial Pancreas Systems Market: Favourable Healthcare Insurance Policies in North America to Boost Adoption of Advanced Diabetes Treatment Options
The Diabetes Type 1 segment is expected to register high Y-o-Y growth rates throughout the forecast period. Revenue contribution of this segment is projected to increase at a CAGR of 12.9% over the forecast period to reach more than US$ 250 Mn by 2026.
View full press release